Fig. 1From: Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyAbsolute difference in time-normalized number of HAE attacks (number/day) during treatment with C1-INH (SC) by subgroup. C1-INH: C1-esterase inhibitor; HAE: hereditary angioedema; N: number of patients; SC: subcutaneous; USA: United States of AmericaBack to article page